HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella results

This article was originally published in The Rose Sheet

Executive Summary

Professional and Cosmetics & Fragrances division combined sales increased 5.3% to $2.68 bil. (€1=$1.20) after adjustment for the year ended June 30, German firm announces Sept. 28. On a nominal basis, revenues of the businesses decreased 8.5% due to "changes in the scope of consolidation." Cosmetics & Fragrances division sales grew 6.2% after adjustment to $983.7 mil. In nominal terms, revenues fell 7.2% as a result of the sale of the North American subsidiary to Procter & Gamble, firm notes. Division's earnings before interest and taxes were $131.3 mil., an increase of 44.3%. Sales of the Professional division were up 4.7% to $1.7 bil. after adjustment for consolidation and currency effects. Wella notes the sales of its consumer business to P&G is almost complete...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel